CEO Matt Gline highlighted 2025 as a year of major milestones, focusing on validating the anti-FcRn franchise with upcoming MG and CIDP data and a central registrational readout for dermatomyositis, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Rheumatologists may be the best clinicians to manage the challenges presented by sarcoidosis, which ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Despite a constellation of available data points regarding prognosis and impacted organs, ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...